We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
iShares S&P 500 Value ETF
IVE
$49.8B
| $6.12M | 0.1% |
35,158
-16,341
| -32% | -$2.63M |
2015 Q2
34 quarters
|
|
127
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
| $5.93M | 0.1% |
140,089
+1,928
| +1% | +$79.5K |
2020 Q4
12 quarters
|
|
128
Vanguard Dividend Appreciation ETF
VIG
$113B
| $5.9M | 0.1% |
34,580
+803
| +2% | +$129K |
2013 Q2
42 quarters
|
|
129
iShares Russell 2000 ETF
IWM
$77.8B
| $5.82M | 0.09% |
28,536
+1,956
| +7% | +$350K |
2013 Q2
42 quarters
|
|
130
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.3B
| $5.49M | 0.09% |
167,089
+1,820
| +1% | +$57.8K |
2022 Q1
7 quarters
|
|
131
JPMorgan Ultra-Short Income ETF
JPST
$42.5B
| $5.39M | 0.09% |
106,755
+17,144
| +19% | +$860K |
2019 Q2
18 quarters
|
|
132
Yum! Brands
YUM
$40.9B
| $5.35M | 0.09% |
40,998
-300
| -0.7% | -$37.4K |
2013 Q2
42 quarters
|
|
133
Schwab US Large- Cap ETF
SCHX
$74.2B
| $5.08M | 0.08% |
269,391
-6,651
| -2% | -$117K |
2013 Q2
42 quarters
|
|
134
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $5.08M | 0.08% |
86,908
-892
| -1% | -$47.7K |
2013 Q2
42 quarters
|
|
135
Cisco
CSCO
$420B
| $5.02M | 0.08% |
99,457
+2,277
| +2% | +$116K |
2013 Q2
42 quarters
|
|
136
Cintas
CTAS
$84.3B
| $4.99M | 0.08% |
33,232
-68
| -0.2% | -$9.11K |
2013 Q2
42 quarters
|
|
137
Honeywell
HON
$66.6B
| $4.9M | 0.08% |
24,846
+1,041
| +4% | +$188K |
2013 Q2
42 quarters
|
|
138
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.8B
| $4.81M | 0.08% |
+93,686
| New | +$4.57M |
2023 Q4
0 quarters
|
|
139
Constellation Brands
STZ
$22.2B
| $4.79M | 0.08% |
19,763
-2,287
| -10% | -$544K |
2019 Q3
17 quarters
|
|
140
Oracle
ORCL
$393B
| $4.77M | 0.08% |
44,933
-1,622
| -3% | -$177K |
2013 Q2
42 quarters
|
|
141
CVS Health
CVS
$119B
| $4.62M | 0.08% |
58,477
-10,430
| -15% | -$742K |
2013 Q2
42 quarters
|
|
142
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11.2B
| $4.51M | 0.07% |
151,582
+4,906
| +3% | +$144K |
2022 Q1
7 quarters
|
|
143
Williams Companies
WMB
$86.1B
| $4.5M | 0.07% |
128,738
+1,510
| +1% | +$53K |
2022 Q1
7 quarters
|
|
144
IBM
IBM
$223B
| $4.44M | 0.07% |
27,108
-5,325
| -16% | -$805K |
2013 Q2
42 quarters
|
|
145
Kimberly-Clark
KMB
$35.1B
| $4.39M | 0.07% |
35,972
-2,263
| -6% | -$274K |
2013 Q2
42 quarters
|
|
146
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
| $4.38M | 0.07% |
92,179
-1,789
| -2% | -$84.7K |
2020 Q1
15 quarters
|
|
147
Stryker
SYK
$114B
| $4.12M | 0.07% |
13,731
+155
| +1% | +$43.5K |
2013 Q2
42 quarters
|
|
148
Schwab US Large-Cap Growth ETF
SCHG
$63.7B
| $4.03M | 0.07% |
193,412
-1,556
| -0.8% | -$30.1K |
2014 Q2
38 quarters
|
|
149
Vanguard Financials ETF
VFH
$13.1B
| $3.98M | 0.06% |
42,926
| – | – |
2013 Q3
41 quarters
|
|
150
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
| $3.93M | 0.06% |
159,182
-4,383
| -3% | -$105K |
2013 Q2
42 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.